By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ohr Pharmaceutical 

1245 Brickyard Road
Suite 590
Salt Lake City  Utah  84106  U.S.A.
Phone: 347-753-4389 Fax: n/a



Company News
Ohr Pharmaceutical (OHRP) Announces Additional Squalamine Eye Drop (OHR-102) Phase 2 Clinical Data In Wet-AMD; The IMPACT Study 8/13/2014 7:28:57 AM
Ohr Pharmaceutical (OHRP) Announces Squalamine Eye Drop (OHR-102) Phase 2 Clinical Data in Retinal Vein Occlusion 8/11/2014 7:26:13 AM
Ohr Pharmaceutical (OHRP) To Present At The 2014 Wedbush Life Sciences Management Access Conference 8/8/2014 8:03:42 AM
Ohr Pharmaceutical (OHRP) Announces Upcoming Squalamine Eye Drop Clinical Data Presentations At The 2014 Annual Meeting Of The American Society Of Retina Specialists 8/7/2014 9:18:51 AM
Ohr Pharmaceutical (OHRP) Added To The Russell Indexes 6/30/2014 7:39:25 AM
Vista Partners Updates Coverage On Ohr Pharmaceutical (OHRP) (NASDAQ: OHRP); Raises Price Target To $31 6/27/2014 10:46:24 AM
Ohr Pharmaceutical (OHRP) To Host Conference Call And Webcast To Discuss Squalamine Interim Phase 2 Data In Wet-AMD 6/24/2014 7:43:48 AM
Ohr Pharmaceutical (OHRP) Eye Drug Falls Short In Phase 2 Trial 6/24/2014 7:00:52 AM
Ohr Pharmaceutical (OHRP) Announces Closing Of SKS Ocular Acquisition; Strengthens Executive Management Team 6/2/2014 9:26:08 AM
Ohr Pharmaceutical (OHRP) Announces Agreement To Acquire Technology Assets Of SKS Ocular 5/16/2014 11:59:21 AM